ETF comparison
IDNA vs XT overlap
Compare IDNA ETF and XT ETF by shared holdings, expense ratio, issuer, category, and tracked overlap.
Tracked overlap5.23%
10 shared holdings
IDNA expense0.00%
Unknown
XT expense0.00%
Unknown
Data date2026-05-01
2026-05-01
Shared top holdings
Overlap uses the smaller fund weight for each shared holding.
ROPROCHE PS PAR AG
MRKMERCK & CO INC
VRTXVERTEX PHARMACEUTICALS INC
GSKGLAXOSMITHKLINE
SANSANOFI SA
REGNREGENERON PHARMACEUTICALS INC
Interpretation
Should you own both IDNA and XT?
IDNA and XT share 10 tracked holdings with 5.23% overlap in the imported holdings set. High overlap can be fine when the funds serve a deliberate role, but it can also mean less diversification than the ticker count suggests.
Use the portfolio analyzer to test your actual allocations. Pairwise overlap does not account for how much of each ETF you own.